Cargando…
Phospho-sulindac inhibits pancreatic cancer growth: NFATc1 as a drug resistance candidate
Phospho-sulindac (P-S), a promising anticancer agent, is efficacious in pre-clinical models of human cancer and is apparently safe. Here, we studied the effect of P-S on pancreatic cancer growth. We found that P-S strongly inhibits the growth of human pancreatic cancer cells in vitro, is efficacious...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
D.A. Spandidos
2013
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3898803/ https://www.ncbi.nlm.nih.gov/pubmed/24284479 http://dx.doi.org/10.3892/ijo.2013.2190 |